- In February 2025, BD announced the launch of its next-generation BD Effivax Glass Prefillable Syringe, designed specifically for mRNA and high-viscosity biologic delivery, with improved break resistance and fill-finish compatibility
- In December 2024, West Pharmaceutical Services partnered with SCHOTT to co-develop a polymer-glass hybrid prefilled syringe system, combining the barrier advantages of glass with the safety of polymers
- In October 2024, Gerresheimer opened a new plant in North Carolina focused on high-volume production of sterile prefilled syringes to meet Europe n demand for injectable biologics
- In August 2024, Nipro Corporation launched its ClearJect syringe line in the U.S., made from COP (cyclic olefin polymer) for improved drug compatibility and ultra-low extractables
- In June 2024, Aptar Pharma announced FDA clearance for its new digital connected prefilled syringe platform, allowing real-time adherence tracking via Bluetooth for chronic disease therapies
